Vesicular Stomatitis Virus Transmission Dynamics Within Its Endemic Range in Chiapas, Mexico.

Autor: Zhou, Lawrence H.¹ (AUTHOR) khanley@nmsu.edu, Valdez, Federico^2,3 (AUTHOR) chad.mire@usda.gov, Lopez Gonzalez, Irene⁴ (AUTHOR) irene.gonzalez@senasica.gob.mx, Freysser Urbina, Willian⁵ (AUTHOR) mvzurbina_86@hotmail.com, Ocaña, Ariadna⁵ (AUTHOR) ariadna.ocana.i@senasica.gob.mx, Tapia, Cristell⁵ (AUTHOR) cristell.tapia.i@senasica.gob.mx, Zambrano, Armando⁵ (AUTHOR) armando.zambrano.i@senasica.gob.mx, Hernandez Solis, Edilberto⁵ (AUTHOR) hersoed.16@hotmail.com, Peters, Debra P. C.⁶ (AUTHOR) deb.peters@usda.gov, Mire, Chad E.³ (AUTHOR), Navarro, Roberto⁷ (AUTHOR), Rodriguez, Luis L.² (AUTHOR) luisvsv@gmail.com, Hanley, Kathryn A.¹ (AUTHOR)

Publikováno v: Viruses (1999-4915). Nov2024, Vol. 16 Issue 11, p1742. 25p.

Virulence factors, antibiotic susceptibility and sequence type distribution of hospital-associated Clostridioides difficile isolates in Israel, 2020-2022.

Autor: Schwartz O; Azrieli Faculty of Medicine, Bar Ilan University, Safed, Israel.; Clinical Microbiology Laboratory, The Edith Wolfson Medical Center, Holon, Israel, affiliated with Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel., Rohana H; Clinical Microbiology Laboratory, Tzafon Medical Center, Poriya, Israel, affiliated with Azrieli Faculty of Medicine, Bar Ilan University, Safed, Israel., Azrad M; Clinical Microbiology Laboratory, Tzafon Medical Center, Poriya, Israel, affiliated with Azrieli Faculty of Medicine, Bar Ilan University, Safed, Israel., Shor A; Shamir Medical Center, B'er Ya'akov, Israel., Rainy N; Shamir Medical Center, B'er Ya'akov, Israel., Maor Y; Infectious Diseases Unit, The Edith Wolfson Medical Center, Holon, Israel.; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel., Nesher L; Infectious Diseases Institute, Soroka University Medical Center, Be'er Sheba, Israel.; Faculty of Health Sciences, Ben-Gurion University of the Negev, Be'er Sheba, Israel., Sagi O; Microbiology Laboratory, Soroka University Medical Center, Be'er Sheba, Israel., Peretz A; Azrieli Faculty of Medicine, Bar Ilan University, Safed, Israel. aperetz@tzmc.gov.il.; Clinical Microbiology Laboratory, Tzafon Medical Center, Poriya, Israel, affiliated with Azrieli Faculty of Medicine, Bar Ilan University, Safed, Israel. aperetz@tzmc.gov.il.

Publikováno v: Scientific reports [Sci Rep] 2024 Sep 04; Vol. 14 (1), pp. 20607. Date of Electronic Publication: 2024 Sep 04.

Efficacy and safety of metabolic interventions for the treatment of severe COVID-19: in vitro, observational, and non-randomized open-label interventional study.

Autor: Ehrlich A; Grass Center for Bioengineering, Benin School of Computer Science and Engineering, Jerusalem, Israel.; Department of Cell and Developmental Biology, Silberman Institute of Life Sciences, Jerusalem, Israel., Ioannidis K; Grass Center for Bioengineering, Benin School of Computer Science and Engineering, Jerusalem, Israel.; Department of Cell and Developmental Biology, Silberman Institute of Life Sciences, Jerusalem, Israel., Nasar M; Division of Infectious Diseases, Barzilai Medical Center, Ashkelon, Israel., Abu Alkian I; Division of Infectious Diseases, Barzilai Medical Center, Ashkelon, Israel., Daskal Y; Grass Center for Bioengineering, Benin School of Computer Science and Engineering, Jerusalem, Israel.; Department of Cell and Developmental Biology, Silberman Institute of Life Sciences, Jerusalem, Israel., Atari N; Central Virology Laboratory, Public Health Services, Ministry of Health and Sheba Medical Center, Tel Hashomer, Israel., Kliker L; Central Virology Laboratory, Public Health Services, Ministry of Health and Sheba Medical Center, Tel Hashomer, Israel., Rainy N; Laboratory Division, Shamir (Assaf Harofeh) Medical Center, Zerifin, Italy., Hofree M; Klarman Cell Observatory, The Broad Institute of Harvard and MIT, Cambridge, United States., Shafran Tikva S; Laboratory Division, Shamir (Assaf Harofeh) Medical Center, Zerifin, Italy.; Hadassah Research and Innovation Center, Jerusalem, Israel.; Department of Nursing, Faculty of School of Life and Health Sciences, The Jerusalem College of Technology Lev Academic Center, Jerusalem, Israel., Houri I; Department of Gastroenterology, Sourasky Medical Center, Tel Aviv, Israel., Cicero A; IRCSS S.Orsola-Malpighi University Hospital, Bologna, Italy., Pavanello C; Centro Grossi Paoletti, Dipartimento di Scienze Farmacologiche e Biomolecolari, Università degli Studi di Milano, Milano, Italy.; Centro Dislipidemie, Niguarda Hospital, Milano, Italy., Sirtori CR; Centro Dislipidemie, Niguarda Hospital, Milano, Italy., Cohen JB; Perelman School of Medicine, University of Pennsylvania, Philadelphia, United States., Chirinos JA; Perelman School of Medicine, University of Pennsylvania, Philadelphia, United States., Deutsch L; BioStats Statistical Consulting Ltd, Modiin, Israel., Cohen M; Grass Center for Bioengineering, Benin School of Computer Science and Engineering, Jerusalem, Israel.; Department of Cell and Developmental Biology, Silberman Institute of Life Sciences, Jerusalem, Israel., Gottlieb A; Division of Infectious Diseases, Barzilai Medical Center, Ashkelon, Israel., Bar-Chaim A; Laboratory Division, Shamir (Assaf Harofeh) Medical Center, Zerifin, Italy., Shibolet O; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel., Mandelboim M; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel., Maayan SL; Division of Infectious Diseases, Barzilai Medical Center, Ashkelon, Israel., Nahmias Y; Grass Center for Bioengineering, Benin School of Computer Science and Engineering, Jerusalem, Israel.; Department of Cell and Developmental Biology, Silberman Institute of Life Sciences, Jerusalem, Israel.

Publikováno v: ELife [Elife] 2023 Jan 27; Vol. 12. Date of Electronic Publication: 2023 Jan 27.

Population differences in antibody response to SARS-CoV-2 infection and BNT162b2 vaccination.

Autor: Shapira G; Department of Cell and Developmental Biology, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.; Edmond J. Safra Center for Bioinformatics, Tel Aviv University, Tel Aviv, Israel., Abu Hamad R; Shamir Medical Center, Be'er Yaacov, Israel., Weiner C; Department of Cell and Developmental Biology, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.; Shamir Medical Center, Be'er Yaacov, Israel., Rainy N; Shamir Medical Center, Be'er Yaacov, Israel., Sorek-Abramovich R; Shamir Medical Center, Be'er Yaacov, Israel., Benveniste-Levkovitz P; Shamir Medical Center, Be'er Yaacov, Israel., Rock R; Shamir Medical Center, Be'er Yaacov, Israel., Avnat E; Department of Cell and Developmental Biology, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel., Levtzion-Korach O; Shamir Medical Center, Be'er Yaacov, Israel., Bar Chaim A; Shamir Medical Center, Be'er Yaacov, Israel., Shomron N; Department of Cell and Developmental Biology, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.; Edmond J. Safra Center for Bioinformatics, Tel Aviv University, Tel Aviv, Israel.

Publikováno v: FASEB journal : official publication of the Federation of American Societies for Experimental Biology [FASEB J] 2022 Apr; Vol. 36 (4), pp. e22223.

Early effectiveness of BNT162b2 Covid-19 vaccine in preventing SARS-CoV-2 infection in healthcare personnel in six Israeli hospitals (CoVEHPI).

Autor: Katz MA; Clalit Research Institute, Innovation Division, Clalit Health Services, Ramat Gan, Israel; School of Public Health, Faculty of Health Sciences, Ben Gurion University of the Negev, Beer Sheva, Israel; University of Michigan, School of Public Health, Ann Arbor, MI, USA., Harlev EB; Schneider Children's Medical Center of Israel, Petach Tikvah, Israel., Chazan B; Infectious Diseases and Infection Control Unit, Ha'Emek Medical Center, Afula, Israel; Rappaport Faculty of Medicine, Technion, Haifa, Israel., Chowers M; Infectious Diseases, Meir Medical Center, Kfar Saba, Israel; Sackler School of Medicine, Tel-Aviv University, Tel Aviv, Israel., Greenberg D; Pediatric Infectious Disease Unit the Pediatric Division, Soroka University Medical Center, Beer Sheva, Israel; Faculty of Health Sciences, Ben Gurion University of the Negev, Beer Sheva, Israel., Peretz A; Occupational Medicine Clinic, Rabin Medical Center, Petah Tikva, Israel., Tshori S; Research Authority, Kaplan Medical Center, Rehovot, Israel; The Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel., Levy J; Clalit Research Institute, Innovation Division, Clalit Health Services, Ramat Gan, Israel., Yacobi M; Clalit Research Institute, Innovation Division, Clalit Health Services, Ramat Gan, Israel., Hirsch A; Clalit Research Institute, Innovation Division, Clalit Health Services, Ramat Gan, Israel., Amichay D; Faculty of Health Sciences, Ben Gurion University of the Negev, Beer Sheva, Israel; Clalit Central Laboratory, Clalit Health Services, Tel Aviv, Israel., Weinberger R; Clalit Central Laboratory, Clalit Health Services, Tel Aviv, Israel., Dor AB; Clalit Central Laboratory, Clalit Health Services, Tel Aviv, Israel., Taraday EK; Clalit Central Laboratory, Clalit Health Services, Tel Aviv, Israel., Reznik D; Schneider Children's Medical Center of Israel, Petach Tikvah, Israel., Chayat CB; Multidisciplinary Laboratory, Schneider Children's Medical Center of Israel, Petach Tikvah, Israel., Sagas D; Clinical Microbiology Laboratory, Ha'Emek Medical Center, Afula, Israel., Zvi HB; Microbiology Department, Rabin Medical Center, Petah Tikva, Israel., Berdinstein R; The Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel; Microbiology Department, Kaplan Medical Center, Rehovot, Israel., Rashid G; Department of Clinical Laboratories, Meir Medical Center, Kfar Saba, Israel., Avni YS; Virology, Soroka University Medical Center, Beer Sheva, Israel., Mandelboim M; Central Virology Laboratory, Chaim Sheba Medical Center, Ministry of Health, Ramat Gan, Israel; Department of Epidemiology and Preventive Medicine, Sackler Faculty of Medicine, School of Public Health, Tel Aviv University, Tel Aviv, Israel., Zuckerman N; Central Virology Laboratory, Chaim Sheba Medical Center, Ministry of Health, Ramat Gan, Israel., Rainy N; Laboratory Division, Shamir Medical Center, Zerifin, Israel., Akriv A; Clalit Research Institute, Innovation Division, Clalit Health Services, Ramat Gan, Israel., Dagan N; Clalit Research Institute, Innovation Division, Clalit Health Services, Ramat Gan, Israel; Software and Information Systems Engineering, Ben Gurion University, Beer Sheva, Israel; Department of Biomedical Informatics, Harvard Medical School, Boston, MA, USA; Ivan and Francesca Berkowitz Family Living Laboratory at Harvard Medical School, Boston, MA, USA., Kepten E; Clalit Research Institute, Innovation Division, Clalit Health Services, Ramat Gan, Israel., Barda N; Clalit Research Institute, Innovation Division, Clalit Health Services, Ramat Gan, Israel; Software and Information Systems Engineering, Ben Gurion University, Beer Sheva, Israel; Department of Biomedical Informatics, Harvard Medical School, Boston, MA, USA; Ivan and Francesca Berkowitz Family Living Laboratory at Harvard Medical School, Boston, MA, USA., Balicer RD; Clalit Research Institute, Innovation Division, Clalit Health Services, Ramat Gan, Israel; School of Public Health, Faculty of Health Sciences, Ben Gurion University of the Negev, Beer Sheva, Israel. Electronic address: Rbalicer@clalit.org.il.

Publikováno v: Vaccine [Vaccine] 2022 Jan 24; Vol. 40 (3), pp. 512-520. Date of Electronic Publication: 2021 Dec 10.